# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
- Durable Clinical Benefit Observed Beyond a Year on Treatment in Heavily Pre-Treated Patients Boston (September 16, 2024) — Al...
Shareholders Approved The Split At September 3, 2024 Annual Meeting, And Split Took Effect On September 11, 2024